Navigation Links
DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product
Date:12/2/2008

DuPont Applied BioSciences has turned to MBI International to join the DuPont team in evaluating the commercial viability of an important bio-based product line. MBI International is a leader in bridging the gap between research and commercialization through collaborative de-risking of bio-based technologies. MBI’s unique “Collaborative De-Risking” process systematically addresses technological uncertainties, which impede new technologies from getting to market.

LANSING, Mich. (Business Wire EON) December 2, 2008 -- "We are very excited that DuPont Applied BioSciences has chosen MBI as a partner to help de-risk this important new product line," stated Dr. Bobby Bringi, recently appointed President of MBI International. "We had the opportunity to work with DuPont Applied BioSciences on an initial phase of this project, and are proud that they have chosen to extend this partnership with MBI."

MBI International fits a unique niche in the marketplace. Virtually all bio-based technology developments that come from the lab need to go through a process development and scale-up stage to determine commercial viability. Once the uncertainties or risks associated with early technological developments are mitigated via de-risking, a company like DuPont Applied BioSciences is better positioned to make product-related investments.

MBI has built a multi-disciplinary team of scientists and engineers, as well as the required pilot-plant facilities, to work collaboratively with industry partners to help address the risks associated with bringing bio-based technologies to market. MBI also provides connectivity with both Michigan State University and the greater university research community to help solve complex problems.

"DuPont Applied BioSciences is pleased to continue our collaboration with MBI on this important new product line,
'/>"/>

Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved  

Page: 1 2

Related biology technology :

1. DuPont Opens Research & Development Center in India
2. DuPont Expands Seed Production Capacity to Meet Growing Demand for Seed, Grain
3. DuPont and State of Delaware Unveil $80 Million Innovation Center Partnership
4. DuPont Meeting Significant 2008 Milestones in Progressing Advanced Biofuels
5. Robert L. Brent, MD, PhD, Honored with 2008 Alfred I. duPont Award for Excellence in Childrens Health Care
6. DuPont Obtains Biotechnology Endorsement for Pioneer(R) Brand Products
7. Pioneer(R) Brand Soybeans From DuPont Deliver Step-Change in Soybean Yields
8. Neogen Acquires Product Line From DuPont Animal Health Solutions
9. DuPont Well Positioned for Long-Term Growth in Agricultural Productivity, Safety and Security, Renewable Energy
10. DuPont Expands Animal Health Solutions Business in Asia
11. DuPont and Genencor Create World-Leading Cellulosic Ethanol Company

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
 DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product 
DuPont Applied BioSciences Selects MBI to Collaborate on Process Development and Scale-Up for New Bio-based Product
(Date:11/27/2009)...ue dye test alternative is helping bring complete...p closer for pharma-companies. It is a non-destruc... by Sepha for use with blister packs and it has ... pharma-companies such as Sanofi-Avenis and Zydus-...ity improvements on the packaging line. Blisters...
(Date:11/25/2009)...RNewswire/ -- Research Triangle Park-based Cnanoz ...reatment water purification system NanoPure(TM) de...inister of Rural Water Supply, Hon. Minister Viswa...nitial tests, performed at Indian Institute of Tec...of the drinking water available in India contains ...
(Date:11/25/2009)...eak at Economic Club of Canada , ...-- Ambassador to Speak at Economic Club of Canada.... International Investment, and Chairman and CEO of...of David Appia go to www.investinfrance.org . , ...th press to discuss recent pro-business initiative...
(Date:11/25/2009)...re/ - Cytochroma today announced the appointment o...Moldt will replace Mr. Ulrik Spork as the Novo A/S... of Board members remains unchanged at six members...t to the board and look forward to benefiting from...es to make progress in becoming a leading CKD-focu...
Breaking Biology Technology:Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 2Sepha's Blue Dye Test Alternative Brings ‘Complete Automation' To Pharma-Packaging Quality Assurance 3North Carolina-based Cnanoz Unveils NanoPure(TM) to Government Leaders in Hyderabad, India 2French Ambassador for International Investment to Visit Toronto December 11 2Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2
...s of cumulative expertise ...30 Tobira,Therapeutics Inc., a clinical stage bio...roduct discovery against life-threatening and life... organization of the company,s,senior management t...ception in 2006 by James Sapirstein, RPh, MBA as C...
...f Cynthia K. French, Ph.D., as Chief Scientific O... Officer, VEDBAEK,...from Affymetrix where she served as Vice President... for building and operating the CLIA,laboratory. P...nt, Chief,Scientific Officer at Speciality Laborat...
...ages 6 to 65, RARITAN, N.J., June 27 ADHD is the...isorder treated in children(1), and,according to t...ween 30,percent and 70 percent of children with AD...(2). ADHD is thought to affect about eight million...d research on the life span of,the condition notes...
Other Biology Technology:Tobira Therapeutics Inc. Announces Senior Management Team 2Tobira Therapeutics Inc. Announces Senior Management Team 3Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer 2Exiqon Appoints Cynthia French as Chief Scientific Officer and Erik Holmlin as Chief Commercial Officer 3FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 2FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 3FDA Approves CONCERTA(R) (methylphenidate HCI) Extended-release Tablets for Treatment of ADHD (Attention Deficit Hyperactivity Disorder) in Adults 4
(Date:11/25/2009)... Dr. Sarit Larisch, Head of the Cell Death Researc...nt of Biology, has been awarded the prestigious Jo...arch exploring the cause of brain cell damage in P...ch year to scientists in support of innovation and... officially conferred earlier this month at an eve...
(Date:11/25/2009)... LA JOLLA, CAWhen you eat may be just as vital to ...the Salk Institute for Biological Studies. Their e...and waning of thousands of genes in the liverthe b...by food intake and not by the body,s circadian clo... time determines the activity of a large number of...
(Date:11/24/2009)...cientists have crystallised a protein that may hel... The protein could be used by probiotic producers ...benefit to people. , "Probiotics need to interact...fect, and if they attach to surfaces in the gut th...exert their activity," says Dr Nathalie Juge from ...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Feeding the clock 2Feeding the clock 3A sticky solution for identifying effective probiotics 2Westaim announces 2009 third quarter results 61351 1Westaim announces 2009 third quarter results 61351 2Westaim announces 2009 third quarter results 61351 3Westaim announces 2009 third quarter results 61351 4Governor Rendell Helps to Break Ground for New Childrens Hospital at Penn State Hershey 61347 1Governor Rendell Helps to Break Ground for New Childrens Hospital at Penn State Hershey 61347 2Lung Cancer Alliance Hails New Mexico Proclamation on Lung Cancer Awareness Month 61343 1Lung Cancer Alliance Hails New Mexico Proclamation on Lung Cancer Awareness Month 61343 2
...oure speaking with may be looking at you, but are ...overtly shifted their attention, without moving th...ain and Mind at The University of Western Ontario ...uring covert attention. His research Neuromuscula...sted on the Advance Online Publication of "Nature ...
...D.C. -- The compound sulforaphane whose natural p... other cruciferous vegetables has been hailed for ...foraphane has demonstrated new skills in treating ...lysis bullosa simplex (EBS), Pierre Coulombe and c...f Medicine in Baltimore report at the American Soc...
... Ill. Individuals with either current or past ins...f insomnia than are those who have never had the s...he December 1 issue of the journal SLEEP. , The s...the cole de psychologie at Universit Laval in Qube... years of age, who completed several questionnaire...
Other Biology News:Natural compound in broccoli could treat devastating genetic skin disorder 2Journal Sleep: Insomniacs are more likely to report a family history of the sleep disorder 2
DNA Engine Thermal Cycler Chassis, w/384-well block from Bio-Rad
Easy Cap Tool from Bio-Rad
...ides were designed to study protein expression pat... species. Tissue slices from three different spec...be treated as a single histological slide for H&E ...dization. This format allows a rapid analysis of ...
...ransfection reagent : jetPEI-RGD is a RGD peptide-...efficient transfection of integrin-expressing epit...on molecules involved in cell-cell and cell-matrix... and most aV-containing proteins, bind multiple Ar...
Biology Products: